Supermax Corporation Berhad (SPMXF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Supermax Corporation Berhad (SPMXF) with AI Score 54/100 (Hold). Supermax Corporation Berhad manufactures and distributes medical gloves and contact lenses. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Supermax Corporation Berhad (SPMXF) Healthcare & Pipeline Overview
Supermax Corporation Berhad, founded in 1987, is a Malaysia-based manufacturer and distributor of medical gloves and contact lenses, exporting to 165 countries. The company operates under the Supermax, Aurelia, and Maxter brands, serving laboratories, pharmacists, hospitals, doctors, and surgeons, while also engaging in biomass energy generation and property holding.
Investment Thesis
Supermax Corporation Berhad presents a mixed investment thesis. The company's established global distribution network across 165 countries provides a strong foundation for revenue generation. However, the company's negative P/E ratio of -3.88 and a negative profit margin of -30.2% raise concerns about its current profitability. The gross margin of 37.8% indicates some efficiency in production, but cost management appears to be a challenge. The company's low beta of 0.16 suggests lower volatility compared to the market. Investors should closely monitor the company's efforts to improve profitability and manage costs effectively.
Based on FMP financials and quantitative analysis
Key Highlights
- Exports to approximately 165 countries, demonstrating a strong global presence.
- Gross margin of 37.8% indicates efficiency in production processes.
- Involved in diverse activities including glove manufacturing, biomass energy generation, and property holding.
- Sells products under established brands: Supermax, Aurelia, and Maxter.
- Beta of 0.16 suggests lower volatility compared to the broader market.
Competitors & Peers
Strengths
- Global distribution network reaching 165 countries.
- Established brand recognition with Supermax, Aurelia, and Maxter.
- Diverse product portfolio including various types of gloves.
- Involvement in multiple business segments.
Weaknesses
- Negative P/E ratio indicating unprofitability.
- Negative profit margin raising concerns about financial performance.
- Dependence on raw material prices.
- Exposure to currency exchange rate fluctuations.
Catalysts
- Expansion of production capacity to meet global demand for medical gloves.
- Development and launch of new glove products with enhanced features.
- Potential partnerships with healthcare providers to expand distribution network.
- Regulatory approvals for new products in key markets.
- Implementation of sustainable manufacturing practices to enhance brand image.
Risks
- Intense competition in the medical glove industry.
- Fluctuations in raw material prices affecting profitability.
- Changes in regulatory requirements impacting market access.
- Economic downturns reducing healthcare spending.
- Negative P/E ratio and profit margin indicating financial challenges.
Growth Opportunities
- Expansion into Emerging Markets: Supermax can focus on expanding its presence in emerging markets with growing healthcare sectors, such as Southeast Asia and Latin America. These regions offer significant growth potential due to increasing healthcare expenditure and rising awareness of hygiene practices. A targeted market entry strategy, including partnerships with local distributors, could drive revenue growth over the next 3-5 years.
- Product Innovation and Diversification: Investing in research and development to introduce new types of medical gloves with enhanced features, such as antimicrobial properties or improved comfort, can differentiate Supermax from its competitors. Diversifying into related healthcare products, such as surgical masks and gowns, can further expand the company's market reach. These initiatives could yield positive results within 2-3 years.
- Strengthening Distribution Channels: Enhancing its distribution network through strategic alliances with hospitals, clinics, and pharmacies can improve Supermax's market penetration. Investing in e-commerce platforms to directly reach end-users can also boost sales. These improvements in distribution efficiency can be realized within the next year.
- Focus on Sustainable Practices: Implementing sustainable manufacturing practices, such as using eco-friendly materials and reducing waste, can enhance Supermax's brand image and attract environmentally conscious customers. Obtaining certifications for sustainable practices can further strengthen the company's competitive advantage. This can build long-term brand equity and customer loyalty.
- Strategic Acquisitions: Acquiring smaller companies with complementary product lines or technologies can accelerate Supermax's growth and expand its market share. Identifying and integrating suitable acquisition targets can provide access to new markets and enhance the company's overall capabilities. The timeline for realizing benefits from acquisitions depends on the integration process, but positive impacts can typically be seen within 1-2 years.
Opportunities
- Expansion into emerging markets.
- Product innovation and diversification.
- Strengthening distribution channels.
- Focus on sustainable practices.
Threats
- Intense competition in the medical glove industry.
- Fluctuations in raw material prices.
- Changes in regulatory requirements.
- Economic downturns affecting healthcare spending.
Competitive Advantages
- Established global distribution network across 165 countries.
- Recognized brands: Supermax, Aurelia, and Maxter.
- Diverse product range including natural rubber and nitrile latex gloves.
- Involvement in multiple business activities: manufacturing, distribution, energy generation, and property holding.
About SPMXF
Supermax Corporation Berhad, established in 1987 and headquartered in Sungai Buloh, Malaysia, operates as an investment holding company focused on the manufacturing, distribution, and marketing of medical gloves and contact lenses. The company’s core business revolves around producing a diverse range of gloves, including natural rubber and nitrile latex variants, alongside personal protective equipment. Supermax caters to a global clientele, exporting its products to approximately 165 countries, encompassing regions such as the United States, the European Union, the Middle East, Asia, and the South Pacific. Beyond its primary manufacturing activities, Supermax is involved in the trading, importing, and distribution of latex gloves. The company also participates in biomass energy generation and property holding. Supermax sells its products under the Supermax, Aurelia, and Maxter brands, targeting laboratories, pharmacists, hospitals, doctors, and surgeons. The company has established a significant presence in the medical supplies market through its diverse product offerings and extensive international distribution network.
What They Do
- Manufactures natural rubber and nitrile latex gloves.
- Distributes medical gloves to various markets.
- Markets medical gloves under the Supermax, Aurelia, and Maxter brands.
- Exports products to approximately 165 countries.
- Trades, imports, and distributes latex gloves.
- Engages in biomass energy generation.
- Participates in property holding activities.
- Offers personal protective equipment.
Business Model
- Manufacturing and selling medical gloves to distributors, hospitals, and healthcare providers.
- Generating revenue through exports to a global network of customers.
- Trading and distributing latex gloves.
- Generating income from biomass energy production.
Industry Context
Supermax Corporation Berhad operates within the medical instruments and supplies industry, a sector driven by healthcare expenditure, regulatory standards, and technological advancements. The global medical glove market is characterized by intense competition among established players and is influenced by factors such as disease outbreaks, hygiene awareness, and healthcare infrastructure development. Supermax competes with companies like CCHWF (Columbia Care Inc.), CKDXF (Check-Cap Ltd.), CLAZF (Clarus Therapeutics Holdings Inc.), DFHL (Dufry AG), and GUERF (Guerbet SA). The company's ability to maintain its market share depends on product innovation, cost competitiveness, and adherence to quality standards.
Key Customers
- Laboratories
- Pharmacists
- Hospitals
- Doctors
- Surgeons
SPMXF Financials
SPMXF Price Today & Live Chart
Supermax Corporation Berhad (SPMXF) stock price: Price data unavailable
SPMXF Latest News
No recent news available for SPMXF.
SPMXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SPMXF.
Price Targets
Wall Street price target analysis for SPMXF.
SPMXF MoonshotScore
What does this score mean?
The MoonshotScore rates SPMXF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Chee Keong Tan
CEO
Chee Keong Tan serves as the CEO of Supermax Corporation Berhad, overseeing the company's operations and strategic direction. His leadership guides a workforce of 1624 employees. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. However, his current position indicates substantial experience in managing a large organization within the healthcare sector.
Track Record: Due to limited information, specific achievements and strategic decisions under Chee Keong Tan's leadership cannot be detailed. However, as CEO, he is responsible for the overall performance of Supermax Corporation Berhad, including navigating the competitive landscape, managing financial performance, and driving growth initiatives. His tenure reflects the company's ongoing presence in the global medical glove market.
SPMXF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum listing requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may not be subject to the same regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for less transparency and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in SPMXF.
- Lower liquidity can lead to difficulty in buying or selling shares.
- Potential for price volatility due to limited trading volume.
- Higher risk of fraud or manipulation compared to stocks on major exchanges.
- OTC Other stocks may not be subject to the same regulatory oversight as listed companies.
- Verify the company's registration and legal standing.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- The company has been in operation since 1987.
- Supermax exports its products to approximately 165 countries.
- The company manufactures and distributes medical gloves and contact lenses.
- Supermax has established brands: Supermax, Aurelia, and Maxter.
SPMXF Healthcare Stock FAQ
What does Supermax Corporation Berhad do?
Supermax Corporation Berhad is a Malaysia-based company that manufactures, distributes, and markets medical gloves and contact lenses. The company offers a variety of natural rubber and nitrile latex gloves, along with personal protective equipment. Supermax exports its products to approximately 165 countries, serving laboratories, pharmacists, hospitals, doctors, and surgeons under the Supermax, Aurelia, and Maxter brands. Additionally, the company is involved in biomass energy generation and property holding activities.
What do analysts say about SPMXF stock?
AI analysis is currently pending for SPMXF. However, based on available financial data, the company has a market capitalization of $0.46 billion, a negative P/E ratio of -3.88, and a negative profit margin of -30.2%. The gross margin stands at 37.8%, and the stock has a beta of 0.16. Investors should conduct thorough due diligence and consider these metrics when evaluating the investment potential of SPMXF.
What are the main risks for SPMXF?
The primary risks for Supermax Corporation Berhad include intense competition in the medical glove industry, fluctuations in raw material prices, and changes in regulatory requirements. The company's negative P/E ratio and profit margin also pose financial risks. Additionally, economic downturns could reduce healthcare spending, impacting demand for the company's products. Investors should carefully assess these risks before investing in SPMXF.
What are the key factors to evaluate for SPMXF?
Supermax Corporation Berhad (SPMXF) currently holds an AI score of 54/100, indicating moderate score. Key strength: Global distribution network reaching 165 countries. Primary risk to monitor: Intense competition in the medical glove industry. This is not financial advice.
How frequently does SPMXF data refresh on this page?
SPMXF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven SPMXF's recent stock price performance?
Recent price movement in Supermax Corporation Berhad (SPMXF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Global distribution network reaching 165 countries. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider SPMXF overvalued or undervalued right now?
Determining whether Supermax Corporation Berhad (SPMXF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying SPMXF?
Before investing in Supermax Corporation Berhad (SPMXF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for CEO background and track record.
- OTC market data may have limited reliability compared to major exchanges.
- AI analysis pending for SPMXF.